David Hallal - Director at iTeos Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
ITOS on Nasdaq
All Insider Reports
All Insider Reports

David Hallal - trading volume in the past year for iTeos Therapeutics, Inc.

Holdings reported by David Hallal for iTeos Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $10.24 Jun 6, 2025 Direct
Stock Option (Right to Buy) 0 Aug 29, 2025 Direct Common Stock

Transactions reported by David Hallal for iTeos Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.